01 December 2004

THE BRM2 monitor, a flagship product of the medical technology company BrainZ Instruments, is being launched and promoted in the United States by GE Healthcare following a deal signed in October.

The monitor allows clinicians to constantly review the brain functions of babies in intensive care and neonatal units for the detection of existing and evolving brain injury.

Nine leading institutions in the United States are currently trialling the monitor, including Johns Hopkins, New York Presbyterian, St Louis Children’s and Thomas Jefferson University in Philadelphia.

The monitors are non-invasive, and have achieved over 85% of the company’s initial target market in New Zealand and Australia during the first year of commercialization.

BrainZ CEO Dr Justin Vaughan says the two year international distribution agreement with GE Healthcare is a significant step in globalizing the market for the BRM2, with launches planned for the UK, Scandinavia, Singapore and Canada in 2005.

“We are delighted that an organization with the global scale and caliber of GE Healthcare wishes to partner with BrainZ Instruments in our efforts to globalize the BRM technology,” says Dr Vaughan.

BrainZ Instruments was established in 2001 to develop the technology invented by Associate Professor Chris Williams and his team at Auckland University. In September 2002, the company was wholly acquired by Tru-test Ltd, a New Zealand multinational company specializing in electronic technologies.

For more information:
www.brainzinstruments.com